io-therapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title - Io Therapeutics,
Description Io Therapeutics, Inc. Immuno-oncology Autoimmune Therapeutics Neurotherapeutics Toggle Navigation Home About Overview Board and Management Advisors Contac
Keywords N/A
Server Information
WebSite io-therapeutics faviconio-therapeutics.com
Host IP 205.186.183.127
Location United States
Related Websites
Site Rank
More to Explore
io-therapeutics.com Valuation
US$1,005
Last updated: 2023-05-01 02:37:44

io-therapeutics.com has Semrush global rank of 0. io-therapeutics.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. io-therapeutics.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 205.186.183.127. According to SiteAdvisor, io-therapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,005
Daily Ads Revenue US$0
Monthly Ads Revenue US$27
Yearly Ads Revenue US$334
Daily Unique Visitors 7
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
io-therapeutics.com. A 3600 IP: 205.186.183.127
io-therapeutics.com. NS 3600 NS Record: ns63.domaincontrol.com.
io-therapeutics.com. NS 3600 NS Record: ns64.domaincontrol.com.
io-therapeutics.com. MX 3600 MX Record: 10 mailstore1.secureserver.net.
io-therapeutics.com. MX 3600 MX Record: 0 smtp.secureserver.net.
io-therapeutics.com. TXT 3600 TXT Record: NETORGFT9585789.onmicrosoft.com
HtmlToTextCheckTime:2023-05-01 02:37:44
Io Therapeutics, Inc. Immuno-oncology Autoimmune Therapeutics Neurotherapeutics Toggle Navigation Home About Overview Board and Management Advisors Contact Pipeline Pipeline IRX4204 IRX5183 Discovery Patents Media Media Releases Publications IRX4204 IRX5183 Posters ABOUT IO THERAPEUTICS Io Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Houston, Texas. The company’s mission is to discover and develop therapeutic compounds targeting nuclear receptors for cancer, neurodegenerative, and autoimmune diseases. NUCLEAR RECEPTOR TARGETED DRUGS Retinoids and Rexinoids are small molecule drugs related to retinoic acid, which control expression of many types of genes through interaction with nuclear receptors. Retinoic acid receptors (RARs) and Retinoic acid X receptors (RXRs) are two of the nuclear receptors activated by retinoic acid and its isomers. Within RARs and RXRs there are three subtypes, designated RARα, β, and γ, and RXRα, β, and γ. Discovery of
HTTP Headers
HTTP/1.1 200 OK
Date: Sat, 23 Oct 2021 18:12:47 GMT
Server: Apache/2.4.39
X-Powered-By: PHP/7.3.11
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Vary: User-Agent
Content-Type: text/html; charset=UTF-8
io-therapeutics.com Whois Information
Domain Name: IO-THERAPEUTICS.COM
Registry Domain ID: 1636431724_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-12-27T21:40:37Z
Creation Date: 2011-01-23T00:19:10Z
Registry Expiry Date: 2025-01-23T00:19:10Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS63.DOMAINCONTROL.COM
Name Server: NS64.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T04:12:19Z <<<